- Identification and characterization of a peptide with affinity to head and neck cancerEva Maria Nothelfer
Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
J Nucl Med 50:426-34. 2009..Targeted therapies, which enhance accumulation of the drug in the tumor, may be realized using tumor-specific binding peptides. This paper identifies and characterizes an HNSCC affine peptide...
- Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticalsRegine Garcia Boy
Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
Mol Imaging Biol 12:377-85. 2010..This study investigates the characteristics of derivatives of the sunflower trypsin inhibitor 1 (SFTI-1), a 14 amino acid peptide with high intrinsic stability...
- The pharmacokinetics of cell-penetrating peptidesDikran Sarko
Department of Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120 Heidelberg, Germany
Mol Pharm 7:2224-31. 2010..In conclusion, CPPs are suitable as drug carriers for in vivo application provided that their pharmacokinetic properties are also considered in design of CPP drug delivery systems...